SEC Form 4 · accession 0001179110-19-001938
CATABASIS PHARMACEUTICALS INC · CATB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joanne T. Beck
Director
Period of report
Feb 13, 2019
Accepted (ET)
Feb 15, 2019 · 8:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454789
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.39 | Feb 13, 2019 | A | 15,000 | A | — | Feb 12, 2029 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1This option was granted on February 13, 2019. The option is scheduled to vest as to one-third of the common stock underlying the option on each anniversay of the grant date until the third anniversary of the grant date.